Web Results

news.bostonscientific.com/2018-04-16-Boston-Scientific-Prevails-In-European-Patent-Dispute-With-Edwards-Lifesciences

Apr 16, 2018 ... The company is also seeking CE mark application for the next-generation transcatheter ... All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. ... iii Abdel-Wahab M et al.

news.bostonscientific.com/2018-02-22-Boston-Scientific-Prices-1-0-Billion-of-Senior-Notes

Feb 22, 2018 ... 22, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) ... all of which are difficult or impossible to predict accurately and many of ...

news.bostonscientific.com/2018-07-20-Boston-Scientific-Announces-Agreement-to-Acquire-Claret-Medical-Inc

Jul 20, 2018 ... Embolic debris such as calcium or tissue can break loose during the procedure, ... 2 Webb, et al., J Am Coll Cardiol Intv. 2015;8:1797-1806.

news.bostonscientific.com/2017-03-09-Boston-Scientific-Receives-Favorable-Rulings-In-Edwards-Lifesciences-Litigation

Mar 9, 2017 ... Boston Scientific Corporation (508) 683-5565 (office) investor_relations@bsci. com. i Kodali SK et al. Two-Year Outcomes after Transcatheter or ...

www.oyez.org/cases/2013/12-1128

Nov 5, 2013 ... Medtronic, Inc. v. Boston Scientific Corp. ... Petitioner. Medtronic Inc. Respondent. Boston Scientific Corp. et al.

www.leagle.com/decision/infdco20170413h79

Apr 12, 2017 ... Pending before the court is Boston Scientific Corporation s BSC...20170413h79. ... THIS DOCUMENT RELATES TO: Peggy Rohroff, et al. v. ...... Autry Cates, Plaintiff, represented by Christopher A. Seeger , SEEGER WEISS ...